Human infections with verocytotoxin-producing Escherichia coli O157-10 years of E. coli O157 serodiagnosis

被引:19
作者
Chart, Henrik [1 ]
Cheasty, Thomas [1 ]
机构
[1] Hlth Protect Agcy, Ctr Infect, Dept Gastrointestinal Emerging & Zoonot Infect, Lab Enter Pathogens, London NW9 5EQ, England
关键词
D O I
10.1099/jmm.0.2008/003632-0
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学]; 100705 [微生物与生化药学];
摘要
From 1997 to 2007, the Laboratory of Enteric Pathogens (LEP), Health Protection Agency, UK, received sera from 2148 patients for testing for antibodies to the LPS of verocytotoxin-producing Escherichia coli (VTEC) O157. A total of 676 (31.5%) sera had antibodies binding the LPS of E. coli O157 and the majority of patients were below the age of 10 years, a trend observed for both males and females. Anti body-positive patients had haemolytic uraemic syndrome (HUS) in 79.3% of cases and most of these presented with the atypical (D-) form of HUS. Nine patients were shown to have antibodies to the LPS of E. coli belonging to serogroups O26 (4), O103 (2), O111 (1) and O145 (2) and one patient had antibodies to the somatic antigens of both E. coli O26 and O103. The serodiagnosis of infections with E. coli O157 and other VTEC continues to be an important adjunct to bacteriology. Where clinicians suspect the involvement of a VTEC in disease, patients' sera should be submitted to the LEP for analysis without delay.
引用
收藏
页码:1389 / 1393
页数:5
相关论文
共 34 条
[1]
Distribution of core oligosaccharide types in lipopolysaccharides from Escherichia coli [J].
Amor, K ;
Heinrichs, DE ;
Frirdich, E ;
Ziebell, K ;
Johnson, RP ;
Whitfield, C .
INFECTION AND IMMUNITY, 2000, 68 (03) :1116-1124
[2]
THE ROLE OF ESCHERICHIA-COLI O-157 INFECTIONS IN THE CLASSICAL (ENTEROPATHIC) HEMOLYTIC UREMIC SYNDROME - RESULTS OF A CENTRAL-EUROPEAN, MULTICENTER STUDY [J].
BITZAN, M ;
LUDWIG, K ;
KLEMT, M ;
KONIG, H ;
BUREN, J ;
MULLERWIEFEL, DE .
EPIDEMIOLOGY AND INFECTION, 1993, 110 (02) :183-196
[3]
The expression of an R3 lipopolysacchadde-core by pathotypes of Escherichia coli [J].
Chart, H ;
Perry, NT ;
Jenkins, C .
JOURNAL OF APPLIED MICROBIOLOGY, 2004, 96 (05) :982-986
[4]
SERUM ANTIBODIES TO ESCHERICHIA-COLI SEROTYPE O157-H7 IN PATIENTS WITH HEMOLYTIC UREMIC SYNDROME [J].
CHART, H ;
SCOTLAND, SM ;
ROWE, B .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (02) :285-290
[5]
Analysis of saliva for antibodies to the LIPS of Escherichia coli O157 in patients with serum antibodies to E-coli O157 LIPS [J].
Chart, H ;
Perry, NT ;
Willshaw, GA ;
Cheasty, T .
JOURNAL OF MEDICAL MICROBIOLOGY, 2003, 52 (07) :569-572
[6]
Production of serum antibodies that recognise epitopes located on the R3 region of Escherichia coli core lipopolysaccharides by patients infected with strains of enterohaemorrhagic E-coli [J].
Chart, H ;
Cheasty, T ;
Willshaw, GA .
JOURNAL OF MEDICAL MICROBIOLOGY, 2002, 51 (12) :1050-1054
[7]
The kinetics of antibody production to antigens of Escherichia coli O157 in a pregnant woman with haemolytic uraemic syndrome [J].
Chart, H ;
Perry, NT ;
Cheasty, T ;
Wright, PA .
JOURNAL OF MEDICAL MICROBIOLOGY, 2002, 51 (06) :522-525
[8]
The pathogenicity of strains of Salmonella paratyphi B and Salmonella java']java [J].
Chart, H .
JOURNAL OF APPLIED MICROBIOLOGY, 2003, 94 (02) :340-348
[9]
Clinical significance of Verocytotoxin-producing Escherichia coli O157 [J].
Chart, H .
WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY, 2000, 16 (8-9) :719-724
[10]
THE SEROLOGICAL RELATIONSHIP BETWEEN ESCHERICHIA-COLI-O157 AND YERSINIA-ENTEROCOLITICA-O9 USING SERA FROM PATIENTS WITH BRUCELLOSIS [J].
CHART, H ;
OKUBADEJO, OA ;
ROWE, B .
EPIDEMIOLOGY AND INFECTION, 1992, 108 (01) :77-85